drugset / Trial / NCT06329622

Effect of Ketosteril on Sarcopenia in Patients With Chronic Kidney Disease

NCT06329622 ↗

Phase 3 Recruiting 58 enrolled Huashan Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The investigators hypothesize that Ketosteril can improve sarcopenia in patients with renal disease without increasing the burden on the kidneys and causing deterioration of renal function. Therefore, this study intends to take patients with CKD stage 3-4 and sarcopenia as the research object, give Ketosteril intervention or not to patients on the base of low-protein diet, and clarify the clinical benefits of Ketosteril prescription for improving sarcopenia in patients with CKD.

Timeline

Start
2024-05-01
Primary completion
2026-06-30
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketosteril Unknown 0.12 g/kg —